October 2024
1. YAKOUT IA, Gallab MM, Mohamed DA, Hamdar H, et al
   Efficacy of metformin drug in preventing metabolic syndrome associated with androgen deprivation therapy (ADT) in prostate cancer patients: A systematic review and meta-analysis.
   Semin Oncol. 2024 Oct 29:S0093-7754(24)00053.
   

   >> Share

   
   May 2024
2. LEUVA H, Moran G, Jamaleddine N, Meseha M, et al
   Assessment of PSA responses and changes in the rate of tumor growth (g-rate) with immune checkpoint inhibitors in US Veterans with prostate cancer.
   Semin Oncol. 2024 May 11:S0093-7754(24)00037.
   

   >> Share

   
   September 2023
3. LONGORIA O, Beije N, de Bono JS
   PARP inhibitors for prostate cancer.
   Semin Oncol. 2023 Sep 25:S0093-7754(23)00062.
   

   >> Share

   
   March 2023
4. HUNG A, Candelieri D, Li Y, Alba P, et al
   Tumor testing and treatment patterns in veterans with metastatic castration-resistant prostate cancer.
   Semin Oncol. 2023 Mar 15:S0093-7754(23)00032.
   

   >> Share

   
   February 2023
5. MENDONCA E SILVA DR, Fernandes GA, Franca E Silva ILA, Curado MP, et al
   Cancer stage and time from cancer diagnosis to first treatment during the COVID-19 pandemic.
   Semin Oncol. 2023;50.
   

   >> Share

   
   September 2022
6. INGROSSO G, Bottero M, Becherini C, Caini S, et al
   A systematic review and meta-analysis on non-metastatic castration resistant prostate cancer: The radiation oncologist's perspective.
   Semin Oncol. 2022 Sep 24. pii: S0093-7754(22)00073.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share